Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 867123, 9 pages
http://dx.doi.org/10.1155/2009/867123
Research Article

Bullatacin Triggered ABCB1-Overexpressing Cell Apoptosis via the Mitochondrial-Dependent Pathway

State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, Guangzhou 510060, China

Received 20 February 2009; Accepted 11 May 2009

Academic Editor: Dominic Fan

Copyright © 2009 Yong-Ju Liang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Takara, T. Sakaeda, and K. Okumura, “An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy,” Current Pharmaceutical Design, vol. 12, no. 3, pp. 273–286, 2006. View at Publisher · View at Google Scholar
  2. R. W. Johnstone, E. Cretney, and M. J. Smyth, “P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death,” Blood, vol. 93, no. 3, pp. 1075–1085, 1999. View at Google Scholar
  3. S. H. Kaufmann and D. L. Vaux, “Alterations in the apoptotic machinery and their potential role in anticancer drug resistance,” Oncogene, vol. 22, no. 6, pp. 7414–7430, 2003. View at Publisher · View at Google Scholar
  4. G. Galati and P. J. O'Brien, “Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties,” Free Radical Biology and Medicine, vol. 37, no. 3, pp. 287–303, 2004. View at Publisher · View at Google Scholar
  5. J. G. Okun, P. Lummen, and U. Brandt, “Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:Ubiquinone oxidoreductase),” The Journal of Biological Chemistry, vol. 274, no. 5, pp. 2625–2630, 1999. View at Publisher · View at Google Scholar
  6. D. J. Morre, R. de Cabo, C. Farley, N. H. Oberlies, and J. L. McLaughlin, “Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes,” Life Sciences, vol. 56, no. 5, pp. 343–348, 1995. View at Google Scholar
  7. N. H. Oberlies, C.-J. Chang, and J. L. McLaughlin, “Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells,” Journal of Medicinal Chemistry, vol. 40, no. 13, pp. 2102–2106, 1997. View at Publisher · View at Google Scholar
  8. N. H. Oberlies, V. L. Croy, M. L. Harrison, and J. L. McLaughlin, “The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells,” Cancer Letters, vol. 115, no. 1, pp. 73–79, 1997. View at Publisher · View at Google Scholar
  9. L.-W. Fu, L.-R. He, Y.-J. Liang et al., “Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2,” Acta Pharmaceutica Sinica, vol. 38, no. 8, pp. 565–570, 2003. View at Google Scholar
  10. L. W. Fu, Y. M. Zhang, Y. J. Liang, X. P. Yang, and Q. C. Pan, “The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells,” European Journal of Cancer, vol. 38, no. 3, pp. 418–426, 2002. View at Publisher · View at Google Scholar
  11. Z. Shi, Y.-J. Liang, Z.-S. Chen et al., “Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo,” Cancer Biology & Therapy, vol. 5, no. 1, pp. 39–47, 2006. View at Google Scholar
  12. K. Hishikawa, B. S. Oemar, F. C. Tanner, T. Nakaki, T. F. Lüscher, and T. Fujii, “Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7,” The Journal of Biological Chemistry, vol. 274, no. 52, pp. 37461–37466, 1999. View at Publisher · View at Google Scholar
  13. X.-H. Wang, D.-Z. Jia, Y.-J. Liang et al., “Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway,” Cancer Letters, vol. 249, no. 2, pp. 256–270, 2007. View at Publisher · View at Google Scholar
  14. Y. Ding, L.-R. He, K.-J. Cao, Y. Lu, L.-Q. Gu, and L.-W. Fu, “Apoptosis of human carcinoma of mouth floor KB cells and multidrug resistant KBv200 cells induced by azide methyl anthraquinone derivative,” Acta Pharmaceutica Sinica, vol. 40, no. 1, pp. 22–26, 2005. View at Google Scholar
  15. S. B. Le, E. L. Holmuhamedov, V. L. Narayanan, E. A. Sausville, and S. H. Kaufmann, “Adaphostin and other anticancer drugs quench the fluorescence of mitochondrial potential probes,” Cell Death and Differentiation, vol. 13, no. 1, pp. 151–159, 2006. View at Publisher · View at Google Scholar
  16. T. Fukazawa, B. Walter, and L. B. Owen-Schaub, “Adenoviral Bid overexpression induces caspase-dependent cleavage of truncated Bid and p53-independent apoptosis in human non-small cell lung cancers,” The Journal of Biological Chemistry, vol. 278, no. 28, pp. 25428–25434, 2003. View at Publisher · View at Google Scholar
  17. J. R. Tormo, N. DePedro, I. Royo et al., “In vitro antitumor structure-activity relationships of threo/trans/threo/ trans/erythro bis-tetrahydrofuranic acetogenins: correlations with their inhibition of mitochondrial complex I,” Oncology Research, vol. 15, no. 3, pp. 129–138, 2005. View at Google Scholar
  18. H.-W. Chih, H.-F. Chiu, K.-S. Tang, F.-R. Chang, and Y.-C. Wu, “Bullatacin, a potent antitumor annonaceous acetogenin, inhibits proliferation of human hepatocarcinoma cell line 2.2.15 by apoptosis induction,” Life Sciences, vol. 69, no. 11, pp. 1321–1331, 2001. View at Publisher · View at Google Scholar
  19. E. Pozo-Guisado, J. M. Merino, S. Mulero-Navarro et al., “Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-?B,” International Journal of Cancer, vol. 115, no. 1, pp. 74–84, 2005. View at Publisher · View at Google Scholar
  20. J. Gordon, C.-H. Wu, M. Rastegar, and A. R. Safa, “β2-microglobulin induces caspase-dependent apoptosis in the CCRF-HSB-2 human leukemia cell line independently of the caspase-3, -8 and -9 pathways but through increased reactive oxygen species,” International Journal of Cancer, vol. 103, no. 3, pp. 316–327, 2003. View at Publisher · View at Google Scholar